Pharmacological effects of low- dose of aspirin on corpus luteum functions in mature cycling female mice

Middle East Fertility Society Journal

Volumn 10, Issue 2, 2005, Pages 150-162

  Al Janabi, Adnan S ^a,b   A Lzohyri, Ahmad M ^a   Al Rubayai, Fouad K ^a  

^a UNIVERSITY OF BAGHDAD   (Iraq)

^b Institute of Embryo Research and Infertility Treatment   (Iraq)

Author keywords

Long term treatment; Low dose aspirin; Ovarian morphology; Uterine morphology

Indexed keywords

ACETYLSALICYLIC ACID; FOLLITROPIN; LUTEINIZING HORMONE; LYSINE ACETYLSALICYLATE; PROGESTERONE;

ANIMAL EXPERIMENT; ARTICLE; BLEEDING; CONTROLLED STUDY; CORPUS LUTEUM FUNCTION; DRUG MECHANISM; ENDOMETRIUM; ESTRUS CYCLE; FEMALE; FOLLITROPIN BLOOD LEVEL; GRANULOSA CELL; LUTEAL PHASE; LUTEINIZING HORMONE BLOOD LEVEL; MOUSE; MYOMETRIUM; NONHUMAN; ORGAN WEIGHT; OVARY; PROGESTERONE BLOOD LEVEL; UTERUS; UTERUS HORN; UTERUS WEIGHT;

EID: 26844435387     PISSN: 11105690     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Hawkey-C.J. COX-2 inhibitors. Lancet. 1999 23:307-14.
2. Blanco-F.J; Guitian-R; Moreno-J; de-Toro-F.J; Galdo-F. effect of anti-inflammatory drugs on COX-1 and COX-2 activity in human articular chondrocytes. J. Rheumatol. 1999;6(6):1366-73.
3. Boyer-J; Rachou-E; Germain-E; Fernandez-H; costs-J; Pouly-J.L; Jopspira-N. Risk factors for extrauterine pregnancy in women using an intrauterine device. Fertil Steril. 2000;74(5):899-908.
4. Rubinstein-M; Marazzi-A; Polack de-Fried-E. Low-dose aspirin treatment improve ovarian responsiveness, uterine and ovarian blood flow velocity, implantation and pregnancy in patients undergoing in vitro fertilization a prospective, randomized, double-blind placebo - controlled assay. Fertile Steril. 1999;71(5):825-9.
5. Kuo-H C, Hsu-C C, Wang-ST, Hung-KE. Aspirin improves uterine blood flow in the peri-implantation period. J. Formos. Med. Assoc. 1997;96(4):253-257.
6. Pharriss-B B, Tillson-S A & Erickson-R R. Prostaglandins in Luteal function. Rec. Prog. Herm. Res. 1972;28:51.
7. Ferida, Khanum-A, Hai-M.A, Choudhury-S.A. Effect of Prostaglandin F2á & it's synthesis inhibitor indomethacin on corpora function in pseudopregnant rats. Bangladesh-Med Res Counc Bull 1981;7(2):96-76.
8. Labhsertwar-AP. Prostaglandin F2á: evidence for Luteolytic effects. Prostaglandins 1972;2:23-31.
9. Labhsertwar-A P. Prostaglandins & the reproductive cycle. Fedration Proc 1974;33:61-77.
10. Diaz-FJ, Crenshaw-TD, Wiltbank-MC. Prostaglandin F2á induces distinct physiological responses in procine corpora Lutea after acquisition of Luteolytic capacity. Biol Reprod 2000;63(5):1504-12.
11. Kormatitsuk-B, Konigrson-K, KindahL-H, Forsberg-M, Madej-A. Clinical signs & hormonal changes in dairy heifers after induction of parturition with Pa F2á. J. Vet. Med. A. Physiol Pathol Clin Med 2000;47(7):395-409.
12. Botting-R, Vane-J. Inflammation & the mechanism of action of anti-inflammatory drugs, FASEB J 1987;1:89-96.
13. Ebodi M. Pharmacology an illustrated review with questions & explanations, 3rd ed., Mechanism of action of aspirin. 1996;P-105.
14. Benson HJ and Talaro KB. Organ system (Rat Dissection) in human anatomy. Benson-H.J. and Talaro-K.B. (ed.) Time mirror company. 1996;P:9-18.
15. Ojanen R, Kaukinen L, Seppala E, Kaukinen S, Vapattalo H. Single dose of acetylsalicylic acid prevent thromboxane release after ischemia. 2003;54(5):986-9.
16. Ganong WF. Review of medical Physiology. A LANGE medical book, 21 ed., McGraw-Hill. 2003
17. Garcia-Rodriguez LA. The effect of non steroidal anti-inflammatory drugs on the risk of coronary heart disease: fusion of clinical pharmacology and pharmacoepidemiologic data. Clin Exp Rheumatol 2001;19(6 suppl. 25):S41-4.
18. Cheng Y, Austin SC, Rocca B, Koller BH, Coffman TM, Grosser T, Lawson JA, Fitz Gerald GA. Role of prostacyclin in the cardiovascular response to thromboxane A2. Science 2002;19;296(5567):539-41.
19. Dumont, A., Flahault, A. Beaufils, M, Verdy E., and Uzan S. Effect of aspirin in pregnant women is dependent on increase bleeding time. Am J Obstet Gynecol; 180(1 Pt 1):135-40.
20. Schafer AI. Effects of non steroidal anti-inflammatory drugs on platelet function & systemic hemostasis. J Clin Pharmacol 1995;35(3):209-19.
21. Patrignani P, Filabozzi P. Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects. J Clin Invest 1982;69:1366-72.
22. Patrono C, Cibattoni G, Patrignani P. Clinical pharmacology of platelet cyclooxygenase inhibition. Circulation 1985;72:1177-1184.
23. Decaterina R, Giannessi D, Bernini W. Low-dose aspirin in patient recovering from myocardial infarction: evidence for a selective inhibition of thromboxane-related platelet function. Eur Heart J 1985;6:409-417.
24. FitzGerald GA, Oates JA, Hawiger J. Endogenous biosynthesis of prostacyclin & thromboxane & platelet function during chronic administration of aspirin in man. J Clin Invest 1983;71:676-688.
25. Dumont A, Merviel P, Berkane N, Gaudet R, Uzan S Risk factor in pre-eclampsia. Press Med 1999;28(39):2189-2196.
26. McCannce KL, Huether SE. Pathophysiology, the biologic bases for disease in adults and children, 2nd ed. Mosby - year book, Inc. The menstrual cycle 1994;P:723.
27. Ivenisevic MOK, Demajo MH, Karakasevic AM, Pantic VR. Regulation of ovarian hyperluteinization. Italian J Anat Embryol 1998;103(4 Suppl. 1):213-25.
28. Endo T, Yamamoto H, Tanaka S. Effect of prostaglandins on progesterone production by human luteal cells & their ability of prostaglandin production. Nippon. Naibunpi Cakkai Zaschi 1988;20;64(8):687-97.
29. Homeida AM, Cooke RC. Effect of Prostaglandin F2á administration on release of endogenous prostaglandin F2á & oxytocin in indomethacin treated goats. Res Vet Sci 1985; 39(1):66-9.
30. Sanchez Criado JE, Lopez F. Effect of indomethacin on progesterone secretion of hysterectomized psuedopregnant rats. Rev Esp Fisiol 1986;42(3):295-9.
31. Freeman ME. The neuroendocrine control of ovarian cycle in the rat. In: Khobil-E; Neill-J(ed): The physiology of 27 Reproduction Col. 12, 2nd ed. New York: Raven press; 1994: 613-658. [Internet]
32. McCracken JA, Custer EE, Lamsa JC. Luteolysis a neuroendocie mediated event. Physiol Rev 1999;79:263-323.
33. Niswender GD, Juengel JL, Silva PJ, Rollyson MK, Mclntush EW. Mechanisms controlling the function & life span of the corpus Luteum. Physiol Rev 2000;80:1-29.
34. Roseff SJ, Bangah ML, Kettel LM et al. Dynamic changes in circulating inhibin levels during the luteal-follicular transition of the human menstrual cycle. J Clin Endocrinol Metab 1989;69:1033.
35. McLachlan RI, Cohen NL, Dahi KD, et al Serum inhibin levels during the periovulatory interval in normal women: Relationships with sex steroid & gonadotrophin levels-Clin Endocrinol (OXF) 1990;32:39.
36. Hafez ESE. Reproduction and breeding techniques for laboratory animals, breeding system, Len & Febiger, Philadelphia. 1970 P:307.
37. Nippoldt TB, Reame NE, Kelch RP, et al. The role of estradiol & progesterone in decreasing luteinizing hormone pulse frequency in the Luteal phase of the menstrual cycle. J Clin Endocrinol Metab 1989;69:67-76.
38. Hall JE, Schoenfeld DH, Martin KA, et al. Hypothalamic gonadotropin-releasing hormone secretion & follicle-stimulating hormone dynamics during he luteal-follicular transition. J Clin Endocrinol Metab 1992;74:600-7.
39. Tarin JJ, Perez-Albala S, Gomez V, Hermonegilo C, Cano A. Stages of estrous cycle at the time of pregnant mare's serum injection effects pre-implantation embryo 28 development in vitro in the mouse. Mol Reprod Dev 2002; 62(3):312-9.
40. Gordon MS, Bartholomew GA, Grinnell AD, Jorgensen CB, White FN. Animal physiology, principles & adaptations, 1982; 4th ed.
41. Jezova M, Scsukova S, Vranova J, Kolena J. Modulation of LH/hCG receptors & physical state of ovarian membranes in rat psuedopregnancy. Gen physiol Biophys 1999;18(4): 347-56.
42. Rodgers RJ, Mitchell MD, Simpson ER. Secretion of progesterone & prostaglandins by cells of bovine corpora lutea from three stages of the Luteal phase. J Endocrinol 1988;118(1):121-61.
43. Rose UM, Hanssen RG, Kloosterboer HJ. Development and characterization of an in vitro ovulation model using mouse ovarian follicles. Biol Reprod 1999;61(2):503-11.
44. Uhler ML, Hus JW, Fisher SG, Zinaman MJ. The effect of NSAIDs on ovulation: a prospective, randomized clinical trial. Fertil Steril 2001;76:957-961.
45. Vander A, Sherman J, Luciano D. Human physiology, the mechanisms of body function, 7th ed., McGraw-Hill, Control of ovarian function 1998;P:654.
46. Pocock G, Richards CD, de Burgh Daly M. Human physiology, the basis of medicine, Oxford University Press, Hormonal regulation of the female reproductive tract. 1999; P:449.
47. Filicori M, Butler JP, Crowley WFJ. Neuroendocrine regulation of the corpus luteum in human-evidence for pulsatile progesterone secretion. J Clin Invest 1984;73:1638.
48. Mais V, Cetel NS, Muse KN, et al. Hormonal dynamics during luteal-follicular transition. J Clin Endocrinol Metab 1987;64:1109.
49. McLachlan RI, Cohen NL, Vale W. The importance of luteinizing hormone in the control of inhibit & progesterone secretion by the human corpus Luteum. J Clin Endocrinol Metal 1989;68:1078:1.
50. Duffy DM, Stewart DR, Stouffer RL Titrating hormone replacement to sustain the structure & function of the corpus luteum after gonadotropin-releasing hormone antagonist treatment in rhesus monkeys. J Clin Endocrinol Metab 1999; 84(1):342-9.
51. Peters KE, Bergfeld EG, Cupp AS, Kojima FN, Mariscal V, Sanchez T, Wehrman ME, Grotjan HE, Hamernik DL, Kittck RJ. LH has a role in the development of fully functioning corpora lutea, but is not required to maintain corpus Luteum function in heifers. Biol Reprod 1994;51(6): 1248-54.
52. West JB. Best and Taylor's physiological basis of medical practice, 12th ed., Williams and Wilkins, Neuroendocrine control of the menstrual cycle. 1990;P:68.
53. Fillicori M, Cognigni GE, Taraborrelli S, Spettoli D, Ciampaglia W, de fatis CT, Pocognoli P. Luteinizing hormone activity supplementation enhances follicle-stimulating hormone efficacy & improves ovulation induction outcome. J Clin Endocrinol Metab 1999; 84(8):2654-36.
54. Moleskaness TA, Woodruff TK, Hess DL, Dahl KD, Stouffer RL. Recombinant human inhibin-A administered early in the menstrual cycle alter concurrent pituitary & 30 follicular, PLUS subsequent Luteal function in rhesus monkeys. J Clin Endocrinol Metab 1996;81:4002-4006.
55. Chaffin CL, Stouffer CL. Role of gonadotropin & progesterone in regulation of morphological remodeling & atresia in the monkey periovulatory follicle. Hum Reprod 2000;15(12):2489-95.
56. Tibbotts TA, Couneely OMO, Malley BW. Progesterone via its receptors antagonizes the pro-inflammatory activity of estrogen in the mouse uterus. Biol Reprod 1999;65(5):1158-65.
57. William. Textbook of endocrinology, 9th edition physiology of estrogen antagonists, progesterone. 1998;P:86.
58. Lessy BA, Killaman AP, Metzger DA. Immunohistochemical analysis of humane uterine estrogen & progesterone receptors throughout the menstrual cycle. J Clin Endocr Metab 1988;69:334-40.